Quarterly report pursuant to Section 13 or 15(d)

SHARE CAPITAL (Tables)

v3.23.3
SHARE CAPITAL (Tables)
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

 

   

September 30,

2023

   

September 30,

2022

 
Warrants     270,762       197,536  
Options     76,185       12,711  
Convertible debentures     2,020,390       114,892  
Total anti-dilutive weighted average shares     2,367,337       325,139